Table 1. Relationship of PRC1 protein levels with clinicopathological characteristics in lung SCC patients.
Characteristics | Number of patients | Cytoplasmic expression | ||
---|---|---|---|---|
Low (≤6.0) | High (>6.0) | P | ||
All patients | 75 | 36 | 39 | |
Gender | 0.203 | |||
Male | 70 | 32 | 38 | |
Female | 5 | 4 | 1 | |
Age | 0.149 | |||
<65 y. o. | 38 | 20 | 18 | |
≥65 y. o. | 37 | 16 | 21 | |
Size of tumor (cm) | 0.251 | |||
≤3 | 23 | 10 | 13 | |
>3 | 52 | 26 | 26 | |
Grade | 0.082 | |||
Low | 14 | 7 | 7 | |
High | 61 | 29 | 32 | |
Lymph node metastasis (pN) | 0.021* | |||
N0 | 41 | 27 | 14 | |
N1–3 | 34 | 9 | 25 | |
p-TNM stages | 0.038* | |||
I | 27 | 20 | 7 | |
II | 19 | 5 | 14 | |
III | 29 | 11 | 18 |
*, P<0.05. PRC1, protein regulator of cytokinesis-1; SCC, squamous cell carcinoma.